Orthopediatrics (NASDAQ:KIDS) issued its quarterly earnings data on Thursday. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.01), Briefing.com reports. The firm had revenue of $20.74 million for the quarter, compared to analyst estimates of $19.87 million. Orthopediatrics had a negative return on equity of 12.92% and a negative net margin of 15.77%. The business’s revenue for the quarter was up 31.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.15) earnings per share.
Shares of NASDAQ KIDS traded up $1.58 during trading on Friday, reaching $37.50. The company had a trading volume of 125,300 shares, compared to its average volume of 74,879. The stock has a 50-day moving average price of $36.29 and a two-hundred day moving average price of $36.98. Orthopediatrics has a twelve month low of $25.11 and a twelve month high of $47.82. The company has a current ratio of 2.53, a quick ratio of 1.75 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $560.98 million, a PE ratio of -39.06 and a beta of 0.23.
Several brokerages recently issued reports on KIDS. BidaskClub cut Orthopediatrics from a “buy” rating to a “hold” rating in a report on Friday. ValuEngine cut Orthopediatrics from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Zacks Investment Research cut Orthopediatrics from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Piper Jaffray Companies lifted their price objective on Orthopediatrics from $40.00 to $44.00 and gave the stock an “overweight” rating in a report on Friday. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $44.40.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Featured Story: How to read a candlestick chart
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.